Genenta Science S.p.A. American Depositary Shares (GNTA) Technical Analysis
$0.65
Market is closed - opens 7 PM, 24 Sep 2026
Insights
- Genenta Science S.p.A. (ADR) is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Genenta Science S.p.A. (ADR) stock suggests that it is a good time to buy
- Based on analysis of the Moving Averages technical indicator, Genenta Science S.p.A. (ADR) stock is in a downtrend↘️
- Based on analysis of the Pivot Points, the current market trend for Genenta Science S.p.A. (ADR) stock suggests that it is a good time to sell or bad time to initiate a fresh position
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 22.86 | Buy |
Stochastic | 4.67, 8.62 | Neutral |
Ultimate Oscillator | 27.03 | Buy |
Stochastic Relative Strength Index | 13.51, 10.32 | Buy |
Moving Average Convergence Divergence | -0.14, -0.14 | Neutral |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.76 | Sell |
20 | 0.87 | Sell |
50 | 1.18 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.76 | Sell |
20 | 0.87 | Sell |
50 | 1.08 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.75 | Sell |
20 | 0.85 | Sell |
50 | 1.19 | Sell |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.65 | Sell |
20 | 0.68 | Sell |
50 | 0.9 | Sell |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 0.65 | Buy |
20 | 0.64 | Sell |
50 | 0.69 | Sell |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 0.77 |
Resistance L2 | 0.75 |
Resistance L1 | 0.73 |
Pivot Point | 0.7 |
Support L1 | 0.68 |
Support L2 | 0.65 |
Support L3 | 0.63 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.